- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
MEF2A Antibody (monoclonal) (M15)Purified Mouse Monoclonal Antibody (Mab)
| Country | United States
Ordering Information
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others 
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AT2835a | 100 ug 400 ul | 7-10 days | $ 315.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
MEF2A Antibody (monoclonal) (M15) - Product info | |
| Application | IF, WB
|
| Primary Accession | Q02078 |
| Reactivity | Human |
| Isotype | IgG2a Kappa |
| Clone Names | 1C8 |
| Calculated MW | 54811 Da |
MEF2A Antibody (monoclonal) (M15) - Additional info | |
| Gene ID 4205 | |
| Other Names ADCAD1, RSRFC4, RSRFC9MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A) | |
| Target/Specificity MEF2A (AAH13437, 71 a.a. ~ 170 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. | |
| Dilution WB~~1:500~1000 | |
| Format Clear, colorless solution in phosphate buffered saline, pH 7.2 . | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions MEF2A Antibody (monoclonal) (M15) is for research use only and not for use in diagnostic or therapeutic procedures. | |
MEF2A Antibody (monoclonal) (M15) - Related products
AP9258c: MEF2A Antibody (Center)
RI13273: MEF2A predesign siRNA
DC07985: Human MEF2A cDNA Clone
LY11555a: MEF2A Over-expression Lysate
BP9258c: MEF2A Antibody (Center) Blocking Peptide
MEF2A Antibody (monoclonal) (M15) - Application data
-
Immunofluorescence of monoclonal antibody to MEF2A (AT2835a) on MCF-7 cell . [antibody concentration 10 ug/ml]
-
MEF2A monoclonal antibody (M15), clone 1C8. Western Blot analysis of MEF2A expression in HepG2 ( Cat # L019V1 ).
MEF2A Antibody (monoclonal) (M15) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
The protein encoded by this gene is a DNA-binding transcription factor that activates many muscle-specific, growth factor-induced, and stress-induced genes. The encoded protein can act as a homodimer or as a heterodimer and is involved in several cellular processes, including muscle development, neuronal differentiation, cell growth control, and apoptosis. Defects in this gene could be a cause of autosomal dominant coronary artery disease 1 with myocardial infarction (ADCAD1). Several transcript variants encoding different isoforms have been found for this gene.
REFERENCES
COMMON VARIANTS IN 40 GENES ASSESSED FOR DIABETES INCIDENCE AND RESPONSE TO METFORMIN AND LIFESTYLE INTERVENTIONS IN THE DIABETES PREVENTION PROGRAM. Jablonski KA, et al. Diabetes, 2010 Aug 3. PMID 20682687.Variation at the NFATC2 Locus Increases the Risk of Thiazolinedinedione-Induced Edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) Study. Bailey SD, et al. Diabetes Care, 2010 Jul 13. PMID 20628086.Dual roles for MEF2A and MEF2D during human macrophage terminal differentiation and c-Jun expression. Aude-Garcia C, et al. Biochem J, 2010 Sep 1. PMID 20590529.Structural changes in exon 11 of MEF2A are not related to sporadic coronary artery disease in Han Chinese population. Dai DP, et al. Eur J Clin Invest, 2010 Aug. PMID 20546016.Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. Rose JE, et al. Mol Med, 2010 Jul-Aug. PMID 20379614.
